Insider Trading Alert - NHI, EPR And LFUS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 4, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.01 to $4,200,565.62.

Highlighted Stocks Traded by Insiders:

National Health Investors (NHI) - FREE Research Report

Mccabe Robert A Jr, who is Director at National Health Investors, bought 200 shares at $62.85 on June 4, 2014. Following this transaction, the Director owned 2,270 shares meaning that the stake was boosted by 9.66% with the 200-share transaction.

The shares most recently traded at $63.36, up $0.51, or 0.81% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 900
  • 12-Week # shares bought: 900
  • 24-Week # shares bought: 1,090

The average volume for National Health Investors has been 179,100 shares per day over the past 30 days. National Health Investors has a market cap of $2.1 billion and is part of the financial sector and real estate industry. Shares are up 11.52% year-to-date as of the close of trading on Wednesday.

National Health Investors, Inc., a real estate investment trust (REIT), invests in health care properties, primarily in the long-term care industry in the United States. The stock currently has a dividend yield of 4.92%. The company has a P/E ratio of 21.0. Currently, there are 2 analysts who rate National Health Investors a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Buy-Rated Dividend Stocks In The Top 3: EPD, NHI, MMP

National Health Investors (NHI) Reaches New Lifetime High Today

Trade-Ideas: National Health Investors (NHI) Is Today's "Barbarian At The Gate" Stock

Best 3 Yielding Buy-Rated Stocks: DUK, NHI, ADC

3 Buy-Rated Dividend Stocks Taking The Lead: UBCP, UBP, NHI